tradingkey.logo
tradingkey.logo
Search

Argenx Announces European Commission Approval Of Vyvgart Subcutaneous Injection

ReutersJun 20, 2025 5:01 PM
facebooktwitterlinkedin

- argenx SE ARGX.BR:

  • ARGENX ANNOUNCES EUROPEAN COMMISSION APPROVAL OF VYVGART SUBCUTANEOUS INJECTION FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

  • EC APPROVES VYVGART SC FOR CIDP IN EUROPE

  • FIRST NOVEL MECHANISM OF ACTION FOR CIDP IN 30 YEARS

  • EC APPROVES VYVGART 1000MG SC INJECTION FOR CIDP

  • EC APPROVAL APPLIES TO EU, ICELAND, LIECHTENSTEIN, NORWAY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI